Biotech Fund Ltd Efficacy serves as Executive at REPROS THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Biotech Fund Ltd Efficacy has executed 6 insider transactions totaling $1.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 16, 2011 involved selling 57,600 shares valued at $55.9K.
Biotech Fund Ltd Efficacy currently holds 8,342,046 shares of REPROS THERAPEUTICS INC. (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotech Fund Ltd Efficacy has been a net buyer of RPRX stock. They have purchased $1.4M and sold $62.5K worth of shares.
Biotech Fund Ltd Efficacy's most recent insider trade was on Feb 16, 2011, when they sold 57,600 shares at $0.97 per share.
Get notified when new Form 4 filings are submitted
| $0.95 |
| Discretionary |
| Oct 17, 2008 | RPRX | $192.6K | Purchase | 30,000 | $6.42 | Discretionary |
| Mar 12, 2008 | RPRX | $425.0K | Purchase | 50,000 | $8.50 | Discretionary |
| Dec 6, 2007 | RPRX | $477.6K | Purchase | 60,000 | $7.96 | Discretionary |
| Dec 5, 2007 | RPRX | $321.5K | Purchase | 39,300 | $8.18 | Discretionary |